Current:Home > ScamsBenjamin Ashford|CVS is pulling some of the most popular cold medicines from store shelves. Here's why. -Mastery Money Tools
Benjamin Ashford|CVS is pulling some of the most popular cold medicines from store shelves. Here's why.
Charles Langston View
Date:2025-04-08 08:55:33
Pharmacy chain CVS Health said it is Benjamin Ashfordpulling some of its most popular cold and cough medications from store shelves, weeks after advisers to the Food and Drug Administration deemed a common ingredient ineffective.
CVS told CBS MoneyWatch that it will no longer sell products that only contain phenylephrine as an active ingredient at its pharmacy stores.
"We are removing certain oral cough and cold products that contain phenylephrine as the only active ingredient from CVS Pharmacy stores," the company said in a statement to CBS MoneyWatch.
"Other oral cough and cold products will continue to be offered to meet consumer needs," CVS added.
CVS said it is aware of the FDA Advisory Committee's position on oral phenylephrine and is committed to complying with all applicable laws and regulations. It is pulling the decongestants voluntarily.
Oral phenylephrine is found in Dayquil, Mucinex Sinus-Max, Sudafed PE Sinus Congestion, Theraflu and other popular medications sold at pharmacies across the U.S.
"Modern studies, when well conducted, are not showing any improvement in congestion with phenylephrine," Dr. Mark Dykewicz, an allergy specialist at the Saint Louis University School of Medicine, said last month.
Decongestants with phenylephrine account for roughly $1.8 billion in annual sales, according to the FDA.
It's unclear if other pharmacies will follow suit and remove drugs in which phenylephrine is the only active ingredient. Walgreens did not say if it will stop selling the medications, telling CBS MoneyWatch that it "follows FDA regulations."
"We are closely monitoring the situation and actively partnering with the Walgreens Office of Clinical Integrity and suppliers on appropriate next steps," a spokesperson told CBS MoneyWatch.
Rite Aid did not immediately reply to a request for comment.
—The Associated Press contributed to this report.
- In:
- Health
- Food and Drug Administration
- CVS
- Health Care
veryGood! (327)
Related
- Arkansas State Police probe death of woman found after officer
- Iowa football to oust Brian Ferentz as offensive coordinator after 2023 season
- Luxury California home — complete with meth lab and contamination — selling for $1.55 million
- Live updates | Israeli ground forces attack Hamas targets in north as warplanes strike across Gaza
- The White House is cracking down on overdraft fees
- Wife of Grammy winner killed by Nashville police sues city over ‘excessive, unreasonable force’
- Americans are still putting way too much food into landfills. Local officials seek EPA’s help
- Magic Johnson becomes the 4th athlete billionaire, according to Forbes
- What to know about Tuesday’s US House primaries to replace Matt Gaetz and Mike Waltz
- Biden and Jill Biden hand out books and candy while hosting thousands for rainy trick or treating
Ranking
- Tom Holland's New Venture Revealed
- FBI investigating antisemitic threats against Jewish community at Cornell University
- Can public officials block you on social media? It's up to the Supreme Court
- Mass shooting in Tampa, Florida: 2 killed, 18 others hurt when gunfire erupts during crowded Halloween street party
- Current, future North Carolina governor’s challenge of power
- Adam Johnson's Partner Ryan Wolfe Pens Heartbreaking Message to Ice Hockey Star After His Tragic Death
- Veterans are more likely than most to kill themselves with guns. Families want to keep them safe.
- Police investigating death of US ice hockey player from skate blade cut in English game
Recommendation
Apple iOS 18.2: What to know about top features, including Genmoji, AI updates
Gas prices continue decline amid Israel-Hamas war, but that could change
Connecticut police officer under criminal investigation for using stun gun on suspect 3 times
How UAW contracts changed with new Ford, GM and Stellantis deals
Toyota to invest $922 million to build a new paint facility at its Kentucky complex
Chase Field roof open for World Series Game 3 between Diamondbacks and Rangers
NFL Week 8 winners, losers: Gruesome game for stumbling Giants
Rare sighting: Tennessee couple spots and encounters albino deer three times in one week